Tumor-peptide-pulsed dendritic cells isolated from spleen or cultured in vitro from bone marrow precursors can provide protection against tumor challenge

Cancer Immunology Immunotherapy

Volumn 44, Issue 6, 1997, Pages 341-347

  Hermans, Ian F ^a   Daish, Angela ^a   Moroni Rawson, Pisana ^a   Ronchese, Franca ^a  

^a MALAGHAN INSTITUTE OF MEDICAL RESEARCH   (New Zealand)

Author keywords

Cytotoxic T lymphocyte; Dendritic cell; Immune response; Tumor immunotherapy; Tumor peptide

Indexed keywords

MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BONE MARROW CELL; CANCER PREVENTION; CELL ISOLATION; CELL PROLIFERATION; CELL TRANSFER; CELL TRANSPLANTATION; CYTOTOXIC T LYMPHOCYTE; DENDRITIC CELL; MAJOR HISTOCOMPATIBILITY COMPLEX; MOUSE; NONHUMAN; PRIORITY JOURNAL; SPLEEN CELL; SUBCUTANEOUS DRUG ADMINISTRATION;

ANIMALS; ANTIGENS, VIRAL; BASE SEQUENCE; BONE MARROW; BONE MARROW CELLS; CANCER VACCINES; CELLS, CULTURED; DENDRITIC CELLS; EPITOPES; FEMALE; GLYCOPROTEINS; IMMUNOTHERAPY, ACTIVE; LYMPHOCYTE ACTIVATION; MALE; MICE; MICE, INBRED C57BL; MOLECULAR SEQUENCE DATA; NEOPLASM PROTEINS; NEOPLASMS, EXPERIMENTAL; PEPTIDE FRAGMENTS; SPLEEN; T-LYMPHOCYTES; T-LYMPHOCYTES, CYTOTOXIC; VIRAL PROTEINS;

EID: 0030790039     PISSN: 03407004     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002620050392     Document Type: Article

References (24)

1. Aichele P, Brduschariem K, Zinkernagel RM, Hengartner H, Pircher H (1995) T cell priming versus T cell tolerance induced by synthetic peptides. J Exp Med 182:261
2. Bonn T, Cerottini J-C, Van den Eynde B, Bruggen P van der, Van Pel A (1994) Tumor antigens recognized by T lymphocytes. Annu Rev Immunol 12:337
3. Boon T, Bruggen P van der (1996) Human tumor antigens recognized by T lymphocytes. J Exp Med 183:725
4. Celluzzi CM, Mayordomo JI, Storkus WJ, Lotze MT, Falo LD (1996) Peptide-pulsed dendritic cells induce antigen-specific. CTL-mediated protective tumor immunity. J Exp Med 183:283
5. Coligan JE, Kruisbeek AM, Margulies DH, Shevach EM, Strober W (1991) Current protocols in immunology. Wiley, New York
6. Cumberbatch M, Kimber I (1992) Dermal tumour necrosis factor-alpha induces dendritic cell migration to draining lymph nodes, and possibly provides one stimulus for Langerhans' cell migration. Immunology 75:257
7. Cumberbatch M, Kimber I (1995) Tumour necrosis factor-alpha is required for accumulation of dendritic cells in draining lymph nodes and for optimal contact sensitization. Immunology 84:31
8. Finlay GJ, Ching L-M, Wilson WR, Baguley BC (1987) Resistance of cultured Lewis lung carcinoma cell lines to tiazofurin. J Natl Cancer Inst 79:291
9. Flamand V, Sornasse T, Thielemans K, Demanet C, Bakkus M, Bazin H, Tielemans F, Leo O, Urbain J, Moser M (1994) Murine dendritic cells pulsed in vitro with tumor antigen induce tumor resistance in vivo. Eur J Immunol 24:605
10. Garrigan K, Moroni-Rawson P, McMurray C, Hermans I, Abernethy N, Watson J, Ronchese F (1996) Functional comparison of spleen dendritic cells and dendritic cells cultured in vitro from bone marrow precursors. Blood 88:3508
11. Gyure LA, Barfoot R, Denham S, Hall JG (1987) Immunity to a syngeneic sarcoma induced in rats by dendritic lymph cells exposed to the tumor either in vivo or in vitro. Br J Cancer 55:17
12. Harding FA, Allison JP (1993) CD28-B7 interactions allow the induction of CD8+ cytotoxic T lymphocytes in the absence of exogenous help. J Exp Med 177:1791
13. Huang AYC, Golumbek P, Ahmadzadeh M, Jaffee E, Pardoll D, Levitsky H (1994) Role of bone marrow-derived cells in presenting MHC class I-restricted tumor antigens. Science (Wash. DC) 264:961
14. Ke Y, Li Y, Kapp JA (1995) Ovalbumin injected with complete Freund's adjuvant stimulates cytolytic responses. Eur J Immunol 25:549
15. Knight SC, Hunt R, Dore C, Medawar PB (1985) Influence of dendritic cells on tumor growth. Proc Natl Acad Sci USA 82:4495
16. Larsen CP, Ritchie SC, Pearson TC, Linsley PS, Lowry RP (1992) Functional expression of the costimulatory molecule, B7/BBI, on murine dendritic cell populations. J Exp Med 176:1215
17. Matzinger P (1991) The JAM test. A simple assay for DNA fragmentation and cell death. J Immunol Methods 145:185
18. Mayordomo JI, Zorina T, Storkus WJ, Zitvogel L, Celluzzi C, Falo LD, Melief CJ, Ildstad ST, Kast WM, Deleo AB, Lotze MT (1995) Bone marrow-derived dendritic cells pulsed with synthetic tumour peptides elicit protective and therapeutic antitumor immunity. Nat Med 1:1297
19. Paglia P, Chiodoni C, Rodolfo M, Colombo MP (1996) Murine dendritic cells loaded in vitro with soluble protein prime cytotoxic T lymphocytes against tumor antigen in vivo. J Exp Med 183:317
20. Pircher H, Buerki K, Lang R, Hengartner H, Zinkernagel RM (1989) Tolerance induction in double specific T-cell receptor transgenic mice varies with antigen. Nature 342:559
21. Porgador A, Gilboa E (1995) Bone marrow-generated dendritic cells pulsed with a class I-restricted peptide are potent inducers of cytotoxic T lymphocytes. J Exp Med 182:255
22. Porgador A, Snyder D, Gilboa E (1996) Induction of antitumor immunity using bone marrow-generated dendritic cells. J Immunol 156:2918
23. Steinman RM (1991) The dendritic cell system and its role in immunogenicity. Annu Rev Immunol 9:271
24. Zitvogel L, Mayordomo JI, Tjandrawan T, Deleo AB, Clarke MR, Lotze MT, Storkus WJ (1996) Therapy of murine tumors with tumor peptide-pulsed dendritic cells - dependence on T cells, B7 costimulation, and T helper cell 1-associated cytokines. J Exp Med 183:87